Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue?()

Fecal microbiota transplantation (FMT) has emerged as a highly effective treatment for Clostridium difficile infection (CDI), the most frequent cause of hospital-acquired infectious diarrhea in developed countries and the cause of nearly 30,000 annual deaths in the US. FMT is proving to be more effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuntz, Mark, des Vignes, Franka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935826/
https://www.ncbi.nlm.nih.gov/pubmed/29736438
http://dx.doi.org/10.1016/j.conctc.2015.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935826/
https://www.ncbi.nlm.nih.gov/pubmed/29736438
http://dx.doi.org/10.1016/j.conctc.2015.11.001

Ejemplares similares